Commission Implementing Decision (EU) 2021/2149 of 3 December 2021 on unresolved objections regarding the terms and conditions of the provisional authorisation of a biocidal product containing 5-Chloro-2-methyl-2H-isothiazol-3-one (C(M)IT) referred by France in accordance with Article 36(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021)8693) (Text with EEA relevance)

This Decision applies to the biocidal product identified by the case number BC-DW041712-25 in the Register for Biocidal Products.

The biocidal product referred to in Article 1 of this Decision is expected to meet the conditions laid down in Article 19(1), points (b)(iii) and (b)(iv), of Regulation (EU) No 528/2012, provided that the provisional authorisations granted by Member States stipulate both of the following conditions: (a) for use 2 (in-can preservation of paints and coatings) and use 7 (preservation of polymer dispersions), as described in the application for the mutual recognition, articles treated with the biocidal product can only be used indoors; (b) the person responsible for the placing on the market of such treated articles ensure that the label of such treated articles provides the following instruction ‘Indoor use only’.

This Decision is addressed to the Member States.